Imaging tracers can be termed as radioactive chemical compounds that are used for the visualization and monitoring the chemical reactions in the cellular and molecular levels. These imaging tracers enable the visualization of organs, cells, when they are being scanned from a CT or PET system. These imaging tracers are injected intravenously inside the human body and then the patients are scanned through the devices where the visualization of organs and cellular are enhanced due to the reaction of isotopes with the molecules.
Global Imaging Tracers Market is expected to grow with a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018, and the historic year of 2017. This rise in market value can be attributed to increase in applications of diagnostic devices and equipments due to the rising prevalence of geriatric population and chronic diseases.
Get Sample Report at :
Competitive Analysis: Global Imaging Tracers Market
Few of the major competitors currently working in Global Imaging Tracers Market are Bayer AG; GENERAL ELECTRIC; Eisai Co., Ltd.; DAIICHI SANKYO COMPANY, LIMITED; 3B Pharmaceuticals; Advanced Accelerator Applications; Blue Earth Diagnostics Limited; Curium; FluoroPharma Medical, Inc.; Ground Fluor Pharmaceuticals, Inc.; Ipsen Group; Cell>Point, L.L.C.; KP Pharmaceutical Technology Inc.; Alliance Medical and Vizient Inc.
Key Pointers Covered in the Global Imaging Tracers Market Trends and Forecast to 2026
- Global Imaging Tracers Market New Sales Volumes
- Global Imaging Tracers Market Replacement Sales Volumes
- Global Imaging Tracers Market Installed Base
- Global Imaging Tracers Market By Brands
- Global Imaging Tracers Market Size
- Global Imaging Tracers Market Procedure Volumes
- Global Imaging Tracers Market Product Price Analysis
- Global Imaging Tracers Market Healthcare Outcomes
- Global Imaging Tracers Market Cost of Care Analysis
- Global Imaging Tracers Market Regulatory Framework and Changes
- Global Imaging Tracers Market Prices and Reimbursement Analysis
- Global Imaging Tracers Market Shares in Different Regions
- Recent Developments for Global Imaging Tracers Market Competitors
- Global Imaging Tracers Market Upcoming Applications
- Global Imaging Tracers Market Innovators Study
Get Detailed TOC:
Key Developments in the Market:
- In June 2018, Alliance Medical announced that they had agreed to acquire Piramal Imaging SA. Piramal Imaging SA will be integrated into the Life Brand and help in providing physicians and doctors enhanced levels of imaging technology.
- In April 2017, IBA Molecular and Mallinckrodt Nuclear Medicine LLC announced the collaboration and formation of This company will be able to offer specialized solution in therapeutic radiopharmaceuticals for PET and SPECT scans.
- Increasing prevalence and adoption of radioactive imaging tracers in diagnostics and clinical applications due to their increased efficiency and effectiveness; this factor is expected to act as a driver for the market growth
- Side effects associated due to the interaction of radioactive materials with the human body; this factor is expected to act as a restraint to the market growth
Inquire Before Buying:
Key insights in the report:
- Complete and distinct analysis of the market drivers and restraints
- Key Market players involved in this industry
- Detailed analysis of the Market Segmentation
- Competitive analysis of the key players involved
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Data Bridge Market Research
Email: [email protected]
Browse Related Report Here: